Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Placebo-Controlled Arm
Conditions
- Parkinsonian Signs in Older Persons
Interventions
- DRUG: Carbidopa 25 mg
- DRUG: Carbidopa-Levodopa 25/100 mg
- DRUG: Placebo 1
- DRUG: Placebo 2
Sponsor
University of Michigan
Collaborators